Literature DB >> 6317180

Sodium-independent taurine binding to brain synaptic membranes.

P Kontro, S S Oja.   

Abstract

Saturable sodium-independent taurine binding to mouse and rat brain synaptic membranes was exposed after two freezing-thawing cycles combined with Triton X-100 treatments. The amount of saturable taurine binding was fairly low but was enhanced after depletion of brain taurine. Saturable taurine binding was displaceable by some convulsants and anticonvulsants but is specificity still remains to be established.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6317180     DOI： 10.1007/bf00735281

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN： 0272-4340            Impact factor:   5.046


  15 in total

1.  The effect of phospholipases and proteases on the binding of gamma-aminobutyric acid to junctional complexes of rat cerebellum.

Authors:  C T Giambalvo; P Rosenberg
Journal:  Biochim Biophys Acta       Date:  1976-07-15

2.  Muscimol binding in rat brain: association with synaptic GABA receptors.

Authors:  K Beaumont; W S Chilton; H I Yamamura; S J Enna
Journal:  Brain Res       Date:  1978-06-09       Impact factor: 3.252

3.  Properties of gamma-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions.

Authors:  S J Enna; S H Snyder
Journal:  Brain Res       Date:  1975-12-12       Impact factor: 3.252

4.  The transport of taurine in the heart and the rapid depletion of tissue taurine content by guanidinoethyl sulfonate.

Authors:  R J Huxtable; H E Laird; S E Lippincott
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

5.  gamma-Aminobutyric acid receptor binding in mammalian brain. Heterogeneity of binding sites.

Authors:  R W Olsen; M O Bergman; P C Van Ness; S C Lummis; A E Watkins; C Napias; D V Greenlee
Journal:  Mol Pharmacol       Date:  1981-03       Impact factor: 4.436

6.  Problems associated with the binding of L-glutamic acid to synaptic membranes: methodological aspects.

Authors:  N A Sharif; P J Roberts
Journal:  J Neurochem       Date:  1980-04       Impact factor: 5.372

7.  [3H]GABA binding in brains from Huntington's chorea patients: altered regulation by phospholipids?

Authors:  K G Lloyd; L Davidson
Journal:  Science       Date:  1979-09-14       Impact factor: 47.728

8.  Hypotaurine uptake by brain slices from adult and 8-day-old mice.

Authors:  S S Oja; P Kontro
Journal:  J Neurochem       Date:  1980-12       Impact factor: 5.372

9.  Taurine binding to membranes from rat brain regions.

Authors:  A M López-Colomé; H Pasantes-Morales
Journal:  J Neurosci Res       Date:  1981       Impact factor: 4.164

10.  Free amino acids in the synaptosome and synaptic vesicle fractions of different bovine brain areas.

Authors:  P Kontro; K M Marnela; S S Oja
Journal:  Brain Res       Date:  1980-02-17       Impact factor: 3.252
View more
  5 in total

Review 1.  Taurine interaction with neurotransmitter receptors in the CNS: an update.

Authors:  Jan Albrecht; Arne Schousboe
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

2.  Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain.

Authors:  Maria Frosini; Casilde Sesti; Stefania Dragoni; Massimo Valoti; Mitri Palmi; Henry B F Dixon; Fabrizio Machetti; Giampietro Sgaragli
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  Taurine as osmoregulator and neuromodulator in the brain.

Authors:  S S Oja; P Saransaari
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

4.  Neuroprotective Mechanisms of Taurine against Ischemic Stroke.

Authors:  Janet Menzie; Howard Prentice; Jang-Yen Wu
Journal:  Brain Sci       Date:  2013-06-03

Review 5.  Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes.

Authors:  Zeinab Rafiee; Alba M García-Serrano; João M N Duarte
Journal:  Nutrients       Date:  2022-03-18       Impact factor: 5.717
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.